1-5 of 5
Juliette Lambert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study

Clinical Trials & Observations
Loïc Vasseur, Laurène Fenwarth, Jérôme Lambert, Stéphane de Botton, Martin Figeac, Céline Villenet, Maël Heiblig, Pierre-Yves Dumas, Christian Récher, Céline Berthon, Emilie Lemasle, Delphine Lebon, Juliette Lambert, Christine Terré, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Meyling Cheok, Raphael Itzykson, Nicolas Duployez
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4024–4034.
https://doi.org/10.1182/bloodadvances.2023010155
Published: 2023
Includes: Supplemental data
Journal Articles

Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study

Antony Ceraulo, Hélène Lapillonne, Meyling H Cheok, Claude Preudhomme, Hervé Dombret, Christine Terré, Juliette Lambert, Guy Leverger, Yves Bertrand, Franck Mortreux, Eric Wattel
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2773–2777.
https://doi.org/10.1182/bloodadvances.2021006040
Published: 2022
Includes: Supplemental data
Journal Articles

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML

Clinical Trials & Observations
Juliette Lambert, Jerome Lambert, Xavier Thomas, Alice Marceau-Renaut, Jean-Baptiste Micol, Aline Renneville, Emmanuelle Clappier, Sandrine Hayette, Christian Récher, Emmanuel Raffoux, Arnaud Pigneux, Celine Berthon, Christine Terré, Karine Celli-Lebras, Sylvie Castaigne, Nicolas Boissel, Philippe Rousselot, Claude Preudhomme, Hervé Dombret, Nicolas Duployez
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5258–5268.
https://doi.org/10.1182/bloodadvances.2021004322
Published: 2021
Includes: Supplemental data
Journal Articles

Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature

Clinical Trials & Observations
Ali Nehme, Hassan Dakik, Frédéric Picou, Meyling Cheok, Claude Preudhomme, Hervé Dombret, Juliette Lambert, Emmanuel Gyan, Arnaud Pigneux, Christian Récher, Marie C. Béné, Fabrice Gouilleux, Kazem Zibara, Olivier Herault, Frédéric Mazurier
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5322–5335.
https://doi.org/10.1182/bloodadvances.2020002042
Published: 2020
Includes: Supplemental data
Journal Articles

Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results

Clinical Trials & Observations
Claude Gardin, Cécile Pautas, Elise Fournier, Raphaël Itzykson, Emilie Lemasle, Jean-Henri Bourhis, Lionel Adès, Jean-Pierre Marolleau, Jean-Valère Malfuson, Lauris Gastaud, Emmanuel Raffoux, Juliette Lambert, Thorsten Braun, Xavier Thomas, Sylvain Chantepie, Thomas Cluzeau, Stéphane de Botton, Céline Berthon, Nicolas Boissel, Nicolas Duployez, Christine Terré, Régis Peffault de Latour, Mauricette Michallet, Karine Celli-Lebras, Claude Preudhomme, Hervé Dombret
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1942–1949.
https://doi.org/10.1182/bloodadvances.2019001349
Published: 2020
Includes: Supplemental data